In force Publication date 13 Apr 15
Development Beta2 adrenoreceptor agonist and elite athletes pharmacokinetics, physiological and pharmacogenetic
Project Title: Beta2 adrenoreceptor agonist and elite athletes: Pharmacokinetics, Physiological and Pharmacogenetic Studies
Researchers: V. Backer (Copenhagen University Hospital, Copenhagen, Denmark), P. Hemmersbach (Doping Control Laboratory, Oslo, Norway), W. Schänzer (Doping Control Laboratory, Cologne, Germany)
Year accepted: 2008
Summary: The two aims were A) to compare concentrations of two short beta2-agonists (SABA) after inhalation and systemic intake, and furthermore two long-acting beta2-agonists (LABA) after inhalation only. B) to compare the distribution of conjugated versus non-conjugated salbutamol.
Available in 1 language.